Accrued Expenses and Other Current Liabilities (Tables)

12 Months Ended

Dec. 31, 2021

Other Liabilities Disclosure [Abstract]

Schedule of Accrued Liabilities

Accrued expenses and other current liabilities consisted of the following:

	December 31,
	2021		2020
Compensation and benefits	$	436,990	$	—
Clinical trial expenses	339,072		126,173
Manufacturing development expenses	—		560,000
Professional fees	345,530		—
Other accrued expenses and other current liabilities	85,529		269,816
Total accrued expenses and other current liabilities	$	1,207,121	$	955,989